MedPath

Odal METastasis in high risk Endometrial Cancer (NOMETEC) PART I: Mapping the lymphatic drainage of the uterus: a feasibility study of the sentinel node procedure.

Recruiting
Conditions
(High Risk) Endometrial Cancer
Registration Number
NL-OMON28134
Lead Sponsor
Diakonessenhuis UtrechtUniversity Medical Center UtrechtUniversity Medical Center St. Radboud NijmegenUniversity Medical Center Maastricht
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

All women, undergoing a diagnostic or therapeutic hysteroscopy because of suspicion for a (benign) lesion of the endometrium (polyps, small myoma, ...)

- All women, undergoing a hysteroscopic curettage and a hysterectomy because of suspicion for a (malignant) lesion of the endometrium.

Exclusion Criteria

Contra-indication for hysteroscopy and/or open abdominal surgery and/or laparoscopic surgery: cervicitis, PID, severe cardiopulmonal or other co-morbidity.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Comparison of the two injection techniques considering their feasibility in mapping the pelvic and para-aortal lymphdrainage routes of the uterus. <br /><br>Primary outcome parameters:<br /><br>Total sentinel node detection rate per injection technique.
Secondary Outcome Measures
NameTimeMethod
- Location of sentinel node detection: pelvic and/or para-aortal<br /><br>- level of para-aortal sentinel node detection (high and/or low)<br>
© Copyright 2025. All Rights Reserved by MedPath